New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Sleep & Sculpt Peptide Therapy in Chicago CJC1295 + Ipamorelin at Better Med Spa BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law FDA's Overreach on Compounded Peptides